Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,573 | 3,514 | N/A | N/A | N/A |
| TOTAL | $4,676 | $3,514 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 39 | N/A | N/A | N/A | N/A |
| TOTAL | $39 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $4,715 | $3,514 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 618 | 542 | 0 | 0 | 0 |
| Accrued Expenses | 1,156 | 115 | N/A | N/A | N/A |
| TOTAL | $1,774 | $657 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 2,500 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 16,285 | 4,000 | 0 | 0 | 0 |
| TOTAL | $16,285 | $6,500 | $N/A | $N/A | $N/A |
| Total Liabilities | $18,059 | $7,157 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Retained earnings | -13,407 | -3,643 | N/A | N/A | N/A |
| TOTAL | $-13,344 | $-3,643 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $4,715 | $3,514 | $0 | $0 | $0 |